Table 1 Baseline characteristics in the control, pituitary-dependent hyperadrenocorticism (PDH), and adrenal-dependent hyperadrenocorticism (ADH) groups

Age (y/o)

10.5 ± 2.8

12.5 ± 2.0

12.3 ± 2.0

Body weight (kg)

6.2 ± 2.7

4.5 ± 1.4

5.9 ± 2.7

Female to male

0.8

1

2

Heart rate (bpm)

128.9 ± 23.4

124.6 ± 16.8

129.3 ± 13.7

Blood pressure (mmHg)

134.6 ± 11.1

140.4 ± 11.0

156.2 ± 16.5^‡†

Incidence of hypertension (%)

0%

10%

56%^‡†

LVEDD (mm)

24.9 ± 3.8

23.6 ± 7.0

21.0 ± 4.8

LVESD (mm)

14.1 ± 2.8

12.9 ± 3.8

12.3 ± 3.1

LVFWd (mm)

4.9 ± 1.1

6.3 ± 1.0^†

6.4 ± 1.0^†

IVSd (mm)

5.1 ± 0.8

6.6 ± 1.2^†

7.1 ± 1.0^‡†

Incidence of LVH (%)

0%

40%^†

56%^†

LA/Ao ratio

1.4 ± 0.1

1.5 ± 0.2

1.4 ± 0.2

EF (%)

75.4 ± 9.5

79.5 ± 5.6

75.0 ± 6.1

FS (%)

43.0 ± 8.0

46.1 ± 5.3

41.3 ± 5.1

Mitral peak E wave (m/s)

0.82 ± 0.33

0.63 ± 0.13

0.52 ± 0.20^†

Mitral E/A ratio

1.07 ± 0.35

0.94 ± 0.29

0.75 ± 0.38

Tricuspid peak E wave (m/s)

0.50 ± 0.16

0.41 ± 0.10

0.46 ± 0.23

Tricuspid E/A ratio

0.97 ± 0.31

0.94 ± 0.23

0.86 ± 0.43

IVRT (mm)

47.9 ± 8.7

57.4 ± 13.7

64.2 ± 20.3^‡†

E/IVRT

1.51 ± 0.34

0.92 ± 0.30^†

0.89 ± 0.42^†